# Adlai Nortye

> Adlai Nortye is a global clinical-stage biopharmaceutical company (Nasdaq: ANL) developing
> differentiated immuno-oncology and precision RAS-pathway targeted cancer medicines. It has
> no public API, developer program, SDK or machine-readable contract. This file is an API
> Evangelist-generated profile index, not a document published by Adlai Nortye.

## Provenance

- Generated: 2026-09-07
- Method: generated (from apis.yml and probes in this repository)
- Not served by the provider: https://www.adlainortye.com/llms.txt returned HTTP 404 on 2026-09-07

## API surface

There is none. Probed on 2026-09-07 across www.adlainortye.com, ir.adlainortye.com and
cn.adlainortye.com: no OpenAPI, Swagger, GraphQL, AsyncAPI, MCP, agent card, apis.json,
llms.txt, or any /.well-known/ discovery document. The apex adlainortye.com does not resolve.
References to "API" in pharmaceutical directories for this company mean Active Pharmaceutical
Ingredient, not an application programming interface.

## Company

- [Home](https://www.adlainortye.com/): corporate site
- [Company Overview](https://www.adlainortye.com/index.php/about): history, mission, global footprint
- [Pipeline](https://www.adlainortye.com/index.php/products): AN9025 (oral pan-RAS(ON) inhibitor), AN4035 (CEACAM5 ADC on the RASiCA platform), AN8025 (T cell / APC modulating fusion protein), AN0025 / palupiprant (oral EP4 antagonist)
- [Press releases](https://www.adlainortye.com/index.php/news): company news and media
- [Business development](https://www.adlainortye.com/index.php/partner_business): partnering and licensing
- [Contact](https://www.adlainortye.com/index.php/contact): offices in Hangzhou, China and New Jersey, USA
- [Careers](https://www.adlainortye.com/index.php/recruit): job opportunities

## Legal

- [Terms of Use](https://www.adlainortye.com/index.php/termOfUse)
- [Privacy Policy](https://www.adlainortye.com/index.php/privacyPolicy)

## Artifacts in this profile

- security/adlai-nortye-domain-security.yml: probed TLS/HSTS/DNSSEC/CAA/SPF/DMARC posture
- well-known/adlai-nortye-well-known.yml: recorded absence across all three hosts